Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹90 Cr
Revenue (TTM)
₹54 Cr
Net Profit (TTM)
₹3 Cr
ROE
14.1 %
ROCE
12 %
P/E Ratio
18.1
P/B Ratio
1.7
Industry P/E
38.99
EV/EBITDA
10.3
Div. Yield
0 %
Debt to Equity
1.2
Book Value
₹18.7
EPS
₹2.3
Face value
10
Shares outstanding
18,132,200
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Onyx Biotec
| -44.8 | -5.7 | -15.3 | -- | -- | -- | -- |
|
BSE Healthcare
| -2.6 | 5.8 | 11.7 | 19.7 | 25.9 | 22.2 | 11.0 |
|
BSE Small Cap
| -2.6 | 9.6 | 21.0 | 6.2 | 27.3 | 35.1 | 17.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Onyx Biotec
|
49.5 | 89.8 | 53.8 | 3.0 | -- | 14.1 | 18.1 | 1.7 |
| 18.2 | 26.3 | 79.9 | 2.0 | -- | 5.9 | 12.7 | 0.8 | |
| 145.0 | 52.9 | 53.5 | -1.6 | 3.8 | -5.1 | -- | 1.8 | |
| 75.7 | 38.2 | 109.0 | -7.3 | -5.4 | -12.8 | -- | 0.7 | |
| 43.0 | 18.7 | 6.5 | 0.5 | -- | 21.1 | 63.1 | 1.7 | |
| 429.2 | 2,353.5 | 193.6 | 17.9 | -- | 97 | 74.1 | 11.3 | |
| 880.6 | 10,564.4 | 6,136.1 | 150.2 | 3.9 | 8.9 | 70.3 | 6.1 | |
| 59.1 | 107.8 | 199.6 | 10.7 | -- | 11.2 | 18.4 | 1.1 | |
| 251.0 | 134.3 | 17.8 | 1.6 | -- | 8.7 | 21.2 | 5.4 | |
| 79.5 | 28.6 | 16.8 | 0.8 | 9.0 | 5.5 | 38.1 | 2.1 |
No Review & Analysis are available.
--
Incorporated
2005
Chairman
--
Managing Director
Sanjay Jain
Headquarters
Solan Dist, Himachal Pradesh
Website
Looking for more details about Onyx Biotec Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Onyx Biotec Ltd stood at ₹ 74 Cr as on 31-Mar-24
The share price of Onyx Biotec Ltd is ₹49.50 (NSE) as of 13-Jun-2025 IST. Onyx Biotec Ltd has given a return of --% in the last 1 years.
Onyx Biotec Ltd has a market capitalisation of ₹ 90 Cr as on 13-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Onyx Biotec Ltd is 1.66 times as on 13-Jun-2025, a 35% discount to its peers’ median range of 2.55 times.
The P/E ratio of Onyx Biotec Ltd is 18.11 times as on 13-Jun-2025, a 54% discount to its peers’ median range of 38.99 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Onyx Biotec Ltd and enter the required number of quantities and click on buy to purchase the shares of Onyx Biotec Ltd.
The prominent promoters of Onyx Biotec Ltd are
| Name of promoters | Holding percentage |
|---|---|
|
NARESH KUMAR |
23.97%
|
|
SANJAY JAIN |
21.48%
|
|
FATEH PAL SINGH |
19.64%
|
The chairman of the company is , and the managing director is Sanjay Jain.
There is no promoter pledging in Onyx Biotec Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,564
|
|
|
2,353
|
|
|
134
|
|
|
108
|
|
|
53
|
|
|
38
|
|
|
29
|
|
|
26
|
|
|
19
|
| Onyx Biotec Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
14.07
|
|
Operating margin(%)
|
11.32
|
|
Net Margin(%)
|
5.63
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Onyx Biotec Ltd was ₹3 Cr.
₹-2.40
(
